A feasibility study of intravenous (IV) paclitaxel, intraperitoneal (IP) carboplatin, and IP paclitaxel in patients with epithelial ovarian carcinoma, fallopian tube carcinoma, or peritoneal carcinoma

被引：0
|
作者：
Nagao, S. [1 ]
Oishi, R. [1 ]
Iwasa, N. [1 ]
Shimizu, M. [1 ]
Hasegawa, K. [1 ]
Goto, T. [1 ]
Fujiwara, K. [1 ]
机构：
[1] Saitama Med Univ Int, Med Ctr, Hidaka City, Saitama, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16549
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Comparison of toxicities between intraperitoneal (IP) versus intravenous (IV) administration of carboplatin in combination with IV paclitaxel.
    Fujiwara, K
    Ishikawa, H
    Kigawa, J
    Akamatsu, N
    Noma, J
    Miyagi, Y
    Okada, M
    Murakami, T
    Nagao, S
    Kohno, I
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 465S - 465S
  • [22] A phase I study of continuous veliparib in combination with IV carboplatin/paclitaxel or IV/IP paclitaxel/cisplatin and bevacizumab in newly diagnosed patients with previously untreated epithelial ovarian, fallopian tube, or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.
    Bell-McGuinn, Katherine M. y
    Brady, William E.
    Schilder, Russell J.
    Fracasso, Paula M.
    Moore, Kathleen N.
    Walker, Joan L.
    Duska, Linda R.
    Mathews, Cara Amanda
    Chen, Alice
    Shepherd, Stacie Peacock
    Giranda, Vincent L.
    Aghajanian, Carol
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [23] Pilot study of outpatient paclitaxel, carboplatin and gemcitabine for advanced stage epithelial ovarian, peritoneal, and fallopian tube cancer
    Micha, JP
    Goldstein, BH
    Rettenmaier, MA
    Mattison, J
    Graham, C
    Birk, CL
    Brown, JV
    GYNECOLOGIC ONCOLOGY, 2004, 94 (03) : 719 - 724
  • [24] Multi-institutional retrospective study of 64 patients with primary fallopian tube carcinoma treated with carboplatin and paclitaxel
    Papaxoinis, G.
    Andreadis, C.
    Fountzilas, G.
    Aravantinos, G.
    Sykiotis, C.
    Akrivos, T.
    Pectasides, D.
    EJC SUPPLEMENTS, 2009, 7 (02): : 469 - 469
  • [25] MANAGEMENT OF PERITONEAL METASTASES IN EPITHELIAL OVARIAN, FALLOPIAN TUBE AND PRIMARY PERITONEAL CARCINOMA
    Gao, Yunong
    ANTICANCER RESEARCH, 2015, 35 (07) : 4301 - 4302
  • [26] A phase 2 feasibility study of nab-paclitaxel and carboplatin in epithelial carcinoma of the uterus
    Pothuri, B.
    Sawaged, Z.
    Karpel, H. C.
    Li, X.
    Lee, J.
    Musa, F.
    Lutz, K.
    Reese, E.
    Blank, S. V.
    Boyd, L. R.
    Curtin, J. P.
    Goldberg, J. D.
    Muggia, F. M.
    GYNECOLOGIC ONCOLOGY, 2024, 190 : 209 - 214
  • [27] Paclitaxel plus Carboplatin Chemotherapy for Primary Peritoneal Carcinoma: A Study of 22 Cases and Comparison with Stage III-IV Ovarian Serous Carcinoma
    Kawaguchi, R.
    Tanase, Y.
    Haruta, S.
    Nagai, A.
    Yoshida, S.
    Furukawa, N.
    Ooi, H.
    Kobayashi, K.
    CASE REPORTS IN ONCOLOGY, 2012, 5 (01): : 173 - 180
  • [28] Quality of life (QOL) results of a randomized study of intravenous (IV) paclitaxel and cisplatin vs IV paclitaxel, intraperitoneal (IP) cisplatin and IP paclitaxel in optimal stage III epithelial ovarian cancer (OC): A Gynecologic Oncology Group trial.
    Wenzel, LB
    Huang, H
    Armstrong, D
    Walker, J
    Cella, D
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 455S - 455S
  • [29] Phase I study of intravenous (IV) docetaxel and intraperitoneal (IP) oxaliplatin in recurrent ovarian and fallopian tube cancer
    Taylor, Sarah E.
    Li, Ruosha
    Petschauer, Jennifer S.
    Donovan, Heidi
    O'Neal, Sara
    Keeler, Amanda W.
    Zamboni, William C.
    Edwards, Robert P.
    Zorn, Kristin K.
    GYNECOLOGIC ONCOLOGY, 2015, 138 (03) : 548 - 553
  • [30] A phase II study of modified dose-dense paclitaxel and every 4 week carboplatin for the treatment of advanced stage primary epithelial ovarian, fallopian tube, or peritoneal carcinoma
    Abaid, L.
    Micha, J.
    Rettenmaier, M.
    Brown, J.
    Mendivil, A.
    Lopez, K.
    Goldstein, B.
    GYNECOLOGIC ONCOLOGY, 2012, 125 : S112 - S112
12345